Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024941229> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2024941229 endingPage "751" @default.
- W2024941229 startingPage "751" @default.
- W2024941229 abstract "Treatment with peginterferon alfa and ribavirin produces a sustained virologic response (SVR) in approximately 60% of hepatitis C virus (HCV)-infected patients. Alternate options are needed for patients who relapse or do not respond to therapy.This prospective, international, multicenter, open-label study evaluated efficacy and safety of peginterferon alfa-2b (1.5 μg/kg/wk) plus weight-based ribavirin (800–1400 mg/day) in 2333 chronic HCV-infected patients with significant fibrosis/cirrhosis whose previous interferon alfa/ribavirin therapy failed. Patients with undetectable HCV-RNA at treatment week (TW) 12 received 48 weeks of therapy; patients with detectable HCV-RNA at TW12 could enter maintenance studies at TW18; 188 patients with low/detectable HCV-RNA at TW12 continued therapy at the investigator's request.Overall, 22% of the patients attained SVR (56% with undetectable HCV-RNA and 12% with low/detectable HCV-RNA at TW12). SVR was better in relapsers (38%) than nonresponders (14%), regardless of previous treatment, and in patients previously treated with interferon-alfa/ribavirin (25%) than peginterferon alfa-ribavirin (17%). Predictors of response in patients with undetectable HCV-RNA at TW12 were genotype (2/3 vs 1, respectively; odds ratio [OR] 2.4; P < .0001), fibrosis score (F2 vs F4; OR, 2.2; F3 vs F4; OR, 1.7; P < .0001), and baseline viral load (≤600,000 vs >600,000 IU/mL; OR, 1.4; P = .0223). These factors plus previous treatment and response were overall predictors of SVR. Safety was similar among fibrosis groups.Peginterferon alfa-2b plus weight-based ribavirin is effective and safe in patients who failed interferon alfa/ribavirin therapy. Genotype, baseline viral load, and fibrosis stage were predictors of response." @default.
- W2024941229 created "2016-06-24" @default.
- W2024941229 creator A5015946967 @default.
- W2024941229 creator A5031530842 @default.
- W2024941229 creator A5044335144 @default.
- W2024941229 creator A5053822600 @default.
- W2024941229 creator A5073144925 @default.
- W2024941229 creator A5079536465 @default.
- W2024941229 date "2003-01-01" @default.
- W2024941229 modified "2023-09-27" @default.
- W2024941229 title "1227 Delayed recovery of pegylated interferon and ribavirin induced anemia" @default.
- W2024941229 doi "https://doi.org/10.1016/s0270-9139(03)81265-x" @default.
- W2024941229 hasPublicationYear "2003" @default.
- W2024941229 type Work @default.
- W2024941229 sameAs 2024941229 @default.
- W2024941229 citedByCount "4" @default.
- W2024941229 countsByYear W20249412292015 @default.
- W2024941229 crossrefType "journal-article" @default.
- W2024941229 hasAuthorship W2024941229A5015946967 @default.
- W2024941229 hasAuthorship W2024941229A5031530842 @default.
- W2024941229 hasAuthorship W2024941229A5044335144 @default.
- W2024941229 hasAuthorship W2024941229A5053822600 @default.
- W2024941229 hasAuthorship W2024941229A5073144925 @default.
- W2024941229 hasAuthorship W2024941229A5079536465 @default.
- W2024941229 hasConcept C126322002 @default.
- W2024941229 hasConcept C142462285 @default.
- W2024941229 hasConcept C203014093 @default.
- W2024941229 hasConcept C2522874641 @default.
- W2024941229 hasConcept C2776178377 @default.
- W2024941229 hasConcept C2776408679 @default.
- W2024941229 hasConcept C2776455275 @default.
- W2024941229 hasConcept C2776461080 @default.
- W2024941229 hasConcept C2777214474 @default.
- W2024941229 hasConcept C2778248108 @default.
- W2024941229 hasConcept C2780040827 @default.
- W2024941229 hasConcept C2781228144 @default.
- W2024941229 hasConcept C2909179924 @default.
- W2024941229 hasConcept C71924100 @default.
- W2024941229 hasConcept C90924648 @default.
- W2024941229 hasConceptScore W2024941229C126322002 @default.
- W2024941229 hasConceptScore W2024941229C142462285 @default.
- W2024941229 hasConceptScore W2024941229C203014093 @default.
- W2024941229 hasConceptScore W2024941229C2522874641 @default.
- W2024941229 hasConceptScore W2024941229C2776178377 @default.
- W2024941229 hasConceptScore W2024941229C2776408679 @default.
- W2024941229 hasConceptScore W2024941229C2776455275 @default.
- W2024941229 hasConceptScore W2024941229C2776461080 @default.
- W2024941229 hasConceptScore W2024941229C2777214474 @default.
- W2024941229 hasConceptScore W2024941229C2778248108 @default.
- W2024941229 hasConceptScore W2024941229C2780040827 @default.
- W2024941229 hasConceptScore W2024941229C2781228144 @default.
- W2024941229 hasConceptScore W2024941229C2909179924 @default.
- W2024941229 hasConceptScore W2024941229C71924100 @default.
- W2024941229 hasConceptScore W2024941229C90924648 @default.
- W2024941229 hasLocation W20249412291 @default.
- W2024941229 hasOpenAccess W2024941229 @default.
- W2024941229 hasPrimaryLocation W20249412291 @default.
- W2024941229 hasRelatedWork W118298973 @default.
- W2024941229 hasRelatedWork W2007857109 @default.
- W2024941229 hasRelatedWork W2008996336 @default.
- W2024941229 hasRelatedWork W2018887507 @default.
- W2024941229 hasRelatedWork W2031380552 @default.
- W2024941229 hasRelatedWork W2077589807 @default.
- W2024941229 hasRelatedWork W2105721917 @default.
- W2024941229 hasRelatedWork W2420998368 @default.
- W2024941229 hasRelatedWork W2440557891 @default.
- W2024941229 hasRelatedWork W48420099 @default.
- W2024941229 hasVolume "38" @default.
- W2024941229 isParatext "false" @default.
- W2024941229 isRetracted "false" @default.
- W2024941229 magId "2024941229" @default.
- W2024941229 workType "article" @default.